Trytosaveabit commented on a stock · May 8 05:12

News

$Avidity Biosciences(RNA.US)$ Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Etedesiran (AOC 1001) For Myotonic Dystrophy Type 1
Benzinga· 3 mins ago

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

1819 Views

Comment

Trytosaveabit

2064Followers

31Following

25KVisitors